Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness
  • Published Date:

    March 13 2019

  • Source:
    PLoS One. 14(3)
  • Language:
    English
Filetype[PDF-470.26 KB]


Details:
  • Alternative Title:
    PLoS One
  • Personal Author:
  • Description:
    Objectives To investigate treatment outcomes and associated characteristics of persons experiencing homelessness who received 12-weekly doses of directly observed isoniazid and rifapentine (3HP/DOT) treatment for latent TB infection (LTBI). Methods Among homeless persons treated with 3HP/DOT during July 2011 –June 2015 in 11 U.S. TB programs, we conducted descriptive analyses of observational data, and identified associations between sociodemographic factors and treatment outcomes. Qualitative interviews were conducted to understand programmatic experiences. Results Of 393 persons experiencing homelessness (median age: 50 years; range: 13–74 years), 301 (76.6%) completed treatment, 55 (14.0%) were lost to follow-up, 18 (4.6%) stopped because of an adverse event (AE), and 19 (4.8%) stopped after relocations or refusing treatment. Eighty-one (20.6%) had at least one AE. Persons aged ≥65 were more likely to discontinue treatment than persons aged 31–44 years. Programs reported difficulty in following up with persons experiencing homelessness because of relocations, mistrust, and alcohol or drug use. Conclusions This study demonstrates the feasibility of administering the 3HP/DOT LTBI regimen to persons experiencing homelessness, a high-risk population.
  • Subject:
  • Pubmed ID:
    30865724
  • Pubmed Central ID:
    PMC6415837
  • Document Type:
    Journal Article
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 365.33 KB]
    Personal Author:
    Marukutira, Tafireyi; Block, Lisa; Alwano, Mary Grace; Behel, Stephanie; Jarvis, Joseph N.; Chakalisa, Unoda; Powis, Kate; Novitsky, Vladimir; Bapati, William; Wang, Huisheng; Ussery, Faith; Lebelonyane, Refeletswe; Mills, Lisa A.; Moore, Janet; Bachanas, Pamela;
    Published Date:
    August 29 2019
    Source:
    PLoS One. 14(8)
    Description:
    IntroductionNon-citizens often face barriers to HIV care and treatment. Quantifying knowledge of positive HIV status and antiretroviral therapy (ART) coverage among non-citizens in a high HIV-prevalence country like Botswana that is close to achievin...
    File Type:
    Filetype[PDF - 365.33 KB]
  2. Filetype[PDF - 320.61 KB]
    Personal Author:
    Smith, Dawn K.; Mendoza, Maria C. B.; Stryker, Jo Ellen; Rose, Charles E.;
    Published Date:
    Jun 03 2016
    Source:
    PLoS One. 11(6).
    Description:
    ObjectivesAs trials were assessing the safety and efficacy of daily oral antiretroviral preexposure prophylaxis (PrEP) for the prevention of HIV infection, there was a clear need to understand the evolution of knowledge of, and attitudes toward, PrEP...
    File Type:
    Filetype[PDF - 320.61 KB]
  3. Filetype[PDF - 2.40 MB]
    Personal Author:
    Abdulai, Abdul Aziz; Agana-Nsiire, Patrick; Biney, Frank; Kwakye-Maclean, Cynthia; Kyei-Faried, Sardick; Amponsa-Achiano, Kwame; Simpson, Shirley Victoria; Bonsu, George; Ohene, Sally-Ann; Ampofo, William Kwabena; Adu-Sarkodie, Yaw; Addo, Kennedy Kwasi; Chi, Kai-Hua; Danavall, Damien; Chen, Cheng Y.; Pillay, Allan; Sanz, Sergi; Tun, Ye; Mitjà, Oriol; Asiedu, Kingsley Bampoe; Ballard, Ronald C.;
    Published Date:
    Mar 22 2018
    Source:
    PLoS Negl Trop Dis. 12(3).
    Description:
    IntroductionThe WHO yaws eradication strategy consists of one round of total community treatment (TCT) of single-dose azithromycin with coverage of > 90%.The efficacy of the strategy to reduce the levels on infection has been demonstrated previously ...
    File Type:
    Filetype[PDF - 2.40 MB]
  4. Filetype[PDF - 1.45 MB]
    Personal Author:
    Gunnala, Rajni; Ogbuanu, Ikechukwu U.; Adegoke, Oluwasegun J.; Scobie, Heather M.; Uba, Belinda V.; Wannemuehler, Kathleen A.; Ruiz, Alicia; Elmousaad, Hashim; Ohuabunwo, Chima J.; Mustafa, Mahmud; Nguku, Patrick; Waziri, Ndadilnasiya Endie; Vertefeuille, John F.;
    Published Date:
    Dec 09 2016
    Source:
    PLoS One. 11(12).
    Description:
    BackgroundDespite recent success towards controlling poliovirus transmission, Nigeria has struggled to achieve uniformly high routine vaccination coverage. A lack of reliable vaccination coverage data at the operational level makes it challenging to ...
    File Type:
    Filetype[PDF - 1.45 MB]
  5. Filetype[PDF - 953.03 KB]
    Personal Author:
    Goodell, Alex J.; Shete, Priya B.; Vreman, Rick; McCabe, Devon; Porco, Travis C.; Barry, Pennan M.; Flood, Jennifer; Marks, Suzanne M.; Hill, Andrew; Cattamanchi, Adithya; Kahn, James G.;
    Published Date:
    April 09 2019
    Source:
    PLoS One. 14(4)
    Description:
    RationaleAs part of the End TB Strategy, the World Health Organization calls for low-tuberculosis (TB) incidence settings to achieve pre-elimination (<10 cases per million) and elimination (<1 case per million) by 2035 and 2050, respectively. These t...
    File Type:
    Filetype[PDF - 953.03 KB]